Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry describes a heterogeneous group of cell types—including mesenchymal stem cells (MSCs), endothelial cells, chondrocytes, and tenocytes—that serve as the biological foundation for regenerative medicine and cell-based therapies. Mesenchymal stem cells are multipotent stromal cells capable of differentiating into various lineages, such as bone and cartilage, while secreting immunomodulatory factors that facilitate tissue repair (Pittenger et al., 1999; Dominici et al., 2006). Endothelial cells are essential for the formation of new blood vessels, a process known as angiogenesis, which is vital for restoring blood supply to damaged tissues (Carmeliet, 2000). Chondrocytes and tenocytes are specialized cells responsible for maintaining the structural integrity of cartilage and tendons, respectively, and are primary targets for treating degenerative musculoskeletal conditions (Archer & Francis-West, 2003; Sharma & Maffulli, 2005). While these cells are not individual molecular targets like receptors or enzymes, they are manipulated via growth factors, scaffolds, or direct transplantation to restore physiological function. Therapeutic interventions often involve the use of signaling molecules like bone morphogenetic protein-2 or platelet-rich plasma to stimulate these cell populations (NIH, 2023).
These cell types facilitate tissue regeneration through paracrine signaling, direct differentiation into specialized tissues, and the modulation of inflammatory environments.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regenerative cell types (Mesenchymal stem cells, endothelial cells, chondrocytes, and tenocytes).